CA2155330A1 - Human neuronal nicotinic acetylcholine receptor compositions and methods employing same - Google Patents

Human neuronal nicotinic acetylcholine receptor compositions and methods employing same

Info

Publication number
CA2155330A1
CA2155330A1 CA002155330A CA2155330A CA2155330A1 CA 2155330 A1 CA2155330 A1 CA 2155330A1 CA 002155330 A CA002155330 A CA 002155330A CA 2155330 A CA2155330 A CA 2155330A CA 2155330 A1 CA2155330 A1 CA 2155330A1
Authority
CA
Canada
Prior art keywords
alpha
subunits
beta
acetylcholine receptor
nicotinic acetylcholine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002155330A
Other languages
French (fr)
Other versions
CA2155330C (en
Inventor
Kathryn J. Elliott
Steven B. Ellis
Michael M. Harpold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Kathryn J. Elliott
Steven B. Ellis
Michael M. Harpold
The Salk Institute Biotechnology/Industrial Associates, Inc.
Sibia Neurosciences, Inc.
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kathryn J. Elliott, Steven B. Ellis, Michael M. Harpold, The Salk Institute Biotechnology/Industrial Associates, Inc., Sibia Neurosciences, Inc., Merck & Co., Inc. filed Critical Kathryn J. Elliott
Publication of CA2155330A1 publication Critical patent/CA2155330A1/en
Application granted granted Critical
Publication of CA2155330C publication Critical patent/CA2155330C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Abstract

Nucleic acids encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing said nucleic acids, methods for producing alpha and beta subunits and recombinant (i.e., isolated or substantially pure) alpha subunits (specifically .alpha.4 and .alpha.7) and beta subunits (specifically (.beta.4) are provided. In addition, combinations of subunits (i.e., .alpha.1, .alpha.2, .alpha.3, .alpha.4, and/or .alpha.7 subunits in combination with .beta.4 subunits; or (.beta.2, .beta.3 and/or .beta.4 subunits in combination with .alpha.4 and/or .alpha.7 subunits) are provided.
CA002155330A 1993-03-08 1994-03-08 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same Expired - Fee Related CA2155330C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2803193A 1993-03-08 1993-03-08
US08/028,031 1993-03-08
PCT/US1994/002447 WO1994020617A2 (en) 1993-03-08 1994-03-08 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same

Publications (2)

Publication Number Publication Date
CA2155330A1 true CA2155330A1 (en) 1994-09-15
CA2155330C CA2155330C (en) 2002-01-29

Family

ID=21841175

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002155330A Expired - Fee Related CA2155330C (en) 1993-03-08 1994-03-08 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same

Country Status (10)

Country Link
US (5) US6022704A (en)
EP (2) EP1508614A1 (en)
JP (2) JP3628691B2 (en)
AT (1) ATE279516T1 (en)
AU (1) AU694424B2 (en)
CA (1) CA2155330C (en)
DE (1) DE69434067T2 (en)
ES (1) ES2229216T3 (en)
GB (1) GB2286397C (en)
WO (1) WO1994020617A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936457B1 (en) * 1990-04-03 2005-08-30 Merck & Co., Inc. DNA ENCODING HUMAN α AND β SUBUNITS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR, CELLS TRANSFORMED THEREWITH, AND RECOMBINANT CELL LINE EXPRESSING A HUMAN α AND β SUBUNIT OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR
ATE279516T1 (en) 1993-03-08 2004-10-15 Merck & Co Inc HUMAN NEURONAL NICOTINE-ACETYLCHOLINE RECEPTOR COMPOUNDS AND METHODS OF THEIR USE
US6485967B1 (en) * 1995-06-07 2002-11-26 Merck & Co., Inc. Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
CA2279675A1 (en) * 1995-12-15 1997-06-16 Enzo Therapeutics, Inc. Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses
US6323000B2 (en) * 1996-12-20 2001-11-27 Clark A. Briggs Variant human α7 acetylcholine receptor subunit, and methods of production and uses thereof
WO1998058074A2 (en) * 1997-06-13 1998-12-23 Allelix Biopharmaceuticals Inc. Assay methods and compositions useful for measuring receptor ligand binding
US6875606B1 (en) * 1997-10-23 2005-04-05 The United States Of America As Represented By The Department Of Veterans Affairs Human α-7 nicotinic receptor promoter
US6632823B1 (en) 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
EP0953637A3 (en) * 1998-03-24 2001-04-25 Smithkline Beecham Plc Acetylcholine receptor
US6252132B1 (en) 1998-11-02 2001-06-26 Institut Pasteur Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor
US6693172B1 (en) 1999-05-27 2004-02-17 Pharmacia And Upjohn Company Double mutant alpha-7 nicotinic acetylcholine receptor
JP2003501022A (en) * 1999-05-27 2003-01-14 ファルマシア・アンド・アップジョン・カンパニー Method for measuring ion channel conductance and composition thereof
GB9913248D0 (en) * 1999-06-09 1999-08-04 Babraham Inst Recombinant nematode nicotinic receptor and uses
US6737270B1 (en) 1999-12-07 2004-05-18 University Of Pittsburgh Of The Commonwealth System Of Higher Education Long-term three dimensional tissue culture system
US20030096411A1 (en) * 1999-12-07 2003-05-22 George Michalopoulos Novel long-term three-dimensional tissue culture system
DE19959582A1 (en) * 1999-12-10 2001-06-13 Bayer Ag Nucleic acids encoding new acetylcholine receptor beta subunits of insects
GB2364385B (en) * 2000-03-29 2002-08-14 Synaptica Ltd Alpha 7 nicotinic receptor screening assays
WO2002016357A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
EP1381603A2 (en) 2000-08-18 2004-01-21 PHARMACIA & UPJOHN COMPANY Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
AU2001284646A1 (en) 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2002215977A1 (en) * 2000-10-31 2002-05-15 Bayer Aktiengesellschaft Regulation of human serotonin receptor precursor
PE20021019A1 (en) 2001-04-19 2002-11-13 Upjohn Co SUBSTITUTED AZABYCLE GROUPS
IL160651A0 (en) * 2001-08-31 2004-07-25 Agensys Inc Nucleic acid and correspondidng protein entitled 205pib5 and pharmaceutical compositions containing the same
JP2005532029A (en) * 2001-09-12 2005-10-27 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Human ion channel
US7229779B2 (en) 2001-09-18 2007-06-12 Abbott Laboratories Variant human α7 acetylcholine receptor subunit, and methods of production and use thereof
US20060126682A1 (en) * 2001-10-08 2006-06-15 Geola Technologies Ltd. Pulsed multiple colour laser system
WO2003095976A2 (en) * 2002-05-09 2003-11-20 Memory Pharmaceuticals Corporation Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
EP1542999A1 (en) * 2002-08-01 2005-06-22 Pharmacia & Upjohn Company LLC 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
US20040151729A1 (en) * 2002-10-28 2004-08-05 George Michalopoulos Novel long-term three-dimensional culture system
US20060142188A1 (en) * 2003-02-14 2006-06-29 Memory Pharmaceuticals Corporation Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof
US7576878B2 (en) * 2003-04-03 2009-08-18 Hewlett-Packard Development Company, L.P. Enhanced management of raster image processing resources
WO2005030145A2 (en) * 2003-09-24 2005-04-07 Targacept, Inc. Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors
US20070249011A1 (en) * 2004-03-04 2007-10-25 Riken Method for Screening Fungus-Specific Antimicrobial Agent and Kit Therefor
EP1684324B1 (en) * 2005-01-20 2011-01-19 LG Electronics Inc. Plasma display panel
CN101180543B (en) * 2005-02-23 2014-06-18 美国陶氏益农公司 Novel assays utilizing nicotinic acetylcholine receptor subunits
US7879913B2 (en) * 2005-06-28 2011-02-01 Catholic Healthcare West Iptakalim hydrochloride for decreasing nicotine use
WO2018057837A1 (en) * 2016-09-23 2018-03-29 Ionis Pharmaceuticals, Inc. Gene therapy and targeted delivery of conjugated compounds
US10538571B2 (en) * 2017-11-27 2020-01-21 Coda Biotherapeutics, Inc. Compositions and methods for neurological diseases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
US4855231A (en) * 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4837148A (en) * 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
US4882279A (en) * 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5024939A (en) * 1987-07-09 1991-06-18 Genentech, Inc. Transient expression system for producing recombinant protein
US4929555A (en) * 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
CA1341554C (en) 1988-03-18 2007-10-09 The Salk Institute For Biological Studies Neuronal nicotinic acetylcholine receptor compositions and assay
US5449606A (en) * 1988-03-18 1995-09-12 The Salk Institute For Biological Studies DNA encoding neuronal nicotinic acetylcholine receptor compositions containing the beta 4 subunit
CA1341170C (en) * 1988-04-04 2001-01-16 Steven B. Ellis Calcium channel compositions and methods
US5386025A (en) * 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
ATE182360T1 (en) * 1989-03-14 1999-08-15 Salk Inst For Biological Studi NEURONAL NICOTINA ACETYLCHOLINE RECEPTOR COMPOSITIONS CONTAINING THE BETA-4 SUBUNIT
CA2067216A1 (en) * 1989-10-25 1991-04-26 Cary Alan Weinberger Receptor infection assay
US5091518A (en) * 1989-11-16 1992-02-25 The Salk Institute For Biological Studies Beta retinoic acid response elements compositions and assays
US5369028A (en) * 1990-04-03 1994-11-29 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
ATE279516T1 (en) 1993-03-08 2004-10-15 Merck & Co Inc HUMAN NEURONAL NICOTINE-ACETYLCHOLINE RECEPTOR COMPOUNDS AND METHODS OF THEIR USE
AU1091595A (en) 1993-11-08 1995-05-29 Salk Institute Biotechnology/Industrial Associates, Inc., The Human neuronal nicotinic acetylcholine receptor compositions and methods employing same

Also Published As

Publication number Publication date
JP3628691B2 (en) 2005-03-16
GB2286397B (en) 1997-09-10
EP1508614A1 (en) 2005-02-23
US5910582A (en) 1999-06-08
JP2004194667A (en) 2004-07-15
EP0688361A1 (en) 1995-12-27
US6303753B1 (en) 2001-10-16
JPH08507441A (en) 1996-08-13
CA2155330C (en) 2002-01-29
WO1994020617A3 (en) 1994-10-27
EP0688361B1 (en) 2004-10-13
WO1994020617A2 (en) 1994-09-15
DE69434067T2 (en) 2006-03-02
US6022704A (en) 2000-02-08
US20020111463A1 (en) 2002-08-15
GB2286397A (en) 1995-08-16
GB9503688D0 (en) 1995-04-12
AU6517394A (en) 1994-09-26
ATE279516T1 (en) 2004-10-15
AU694424B2 (en) 1998-07-23
ES2229216T3 (en) 2005-04-16
GB2286397C (en) 1997-09-10
US6664375B2 (en) 2003-12-16
DE69434067D1 (en) 2004-11-18
US5837489A (en) 1998-11-17

Similar Documents

Publication Publication Date Title
CA2155330A1 (en) Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
AU693747B2 (en) Imidazo(4,5-c)pyridin-4-amines
CA2347979A1 (en) Treatment of skin with adenosine or adenosine analog
SI0866876T1 (en) Process for the preparation of recombinant proteins in e.coli by high cell density fermentation
EP1308515A3 (en) Porcine factor VIII
AU7264694A (en) Defective adenovirus vectors and use thereof in gene therapy
ZA967562B (en) Materials and methods relating to the attachment and display of substances on cell surfaces.
AU6266496A (en) Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
CA2147623A1 (en) Novel p-selectin ligand protein
CA2306449A1 (en) Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
GB2287941A (en) Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
AU8209187A (en) Hybrid proteins
CA2085469A1 (en) Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons
GR3022080T3 (en) T-cell receptor gene located within alpha locus and dna constructions
PL306291A1 (en) C-protein obtaining method
AU2596888A (en) Peptide structures, immunogens containing them and their uses in the control of fertility
CA2108358A1 (en) Gene expression in bacilli
EP0284205A3 (en) Carbomycin biosynthetic gene, designated carg, for use in streptomyces and other organisms
CA2115151A1 (en) Tau/neurofilament protein kinases pk40 and pk36
ZA946008B (en) Novel tripeptides useful in immune and cns therapy
EP0317279A3 (en) Peptides for use in the purification of factor viii
AU1492692A (en) Co-expression in eukaryotic cells
MX9700255A (en) METHOD FOR IDENTIFYING NUCLEIC ACIDS ENCODING c-fos PROMOTER ACTIVATING PROTEINS.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed